News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,854 Results
Type
Article (1921)
Company Profile (2)
Press Release (71931)
Section
Business (25332)
Career Advice (9)
Deals (4552)
Drug Development (8160)
FDA (1804)
Job Trends (801)
News (37019)
Policy (3561)
Tag
2027 BioCapital Standard (1)
Academia (99)
Accelerated approval (5)
ADA (2)
Allergies (25)
Alliances (8165)
ALS (20)
Alzheimer's disease (192)
Antibody-drug conjugate (ADC) (127)
Approvals (1983)
Artificial intelligence (40)
ASCO (38)
Autoimmune disease (40)
Automation (2)
Bankruptcy (9)
Best Places to Work (585)
BIO (9)
Biologics (1)
Biosimilars (98)
BioSpace Insights (1)
Biotechnology (5)
Bladder cancer (32)
Brain cancer (8)
Breast cancer (65)
Cancer (681)
Cardiovascular disease (26)
Career advice (9)
CAR-T (18)
CDC (2)
CDMO (9)
Celiac Disease (1)
Cell therapy (64)
Cervical cancer (5)
Clinical research (7771)
Collaboration (356)
Commercialization (3)
Compensation (28)
Complete response letters (7)
COVID-19 (200)
CRISPR (1)
C-suite (112)
Cystic fibrosis (8)
Data (911)
Depression (18)
Dermatology (12)
Diabetes (46)
Diagnostics (657)
Digital health (7)
Drug discovery (46)
Drug pricing (1)
Duchenne muscular dystrophy (47)
Earnings (8263)
Events (7662)
Executive appointments (80)
FDA (2359)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (169)
Gene editing (7)
Generative AI (1)
Gene therapy (42)
GLP-1 (84)
Government (246)
Grass and pollen (1)
Guidances (40)
Healthcare (1098)
Hematology (14)
HIV (7)
Huntington's disease (3)
IgA nephropathy (27)
Immunology and inflammation (7)
Immuno-oncology (12)
Indications (30)
Infectious disease (228)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (44)
IPO (1640)
Job creations (242)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Kidney disease (6)
Layoffs (7)
Legal (953)
Licensing (11)
Liver cancer (22)
Longevity (3)
Lung cancer (129)
Lymphoma (57)
Machine learning (1)
Manufacturing (152)
Marketing (4)
MASH (19)
Medical device (1178)
Medtech (1199)
Mergers & acquisitions (3126)
Metabolic disorders (119)
mRNA (8)
Multiple sclerosis (28)
NASH (1)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (368)
NextGen: Class of 2026 (219)
Non-profit (64)
Obesity (42)
Opinion (1)
Ovarian cancer (35)
Pain (22)
Pancreatic cancer (33)
Parkinson's disease (51)
Partnered (4)
Patents (79)
Patient recruitment (92)
Patient selection (2)
Peanut (2)
People (5221)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2097)
Phase 2 (3295)
Phase 3 (2932)
Pipeline (1431)
Policy (1)
Postmarket research (241)
Preclinical (711)
Press Release (2)
Prostate cancer (28)
Radiopharmaceuticals (29)
Rare diseases (94)
Real estate (606)
Regenerative medicine (1)
Regulatory (3111)
Reports (9)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (25)
Series A (35)
Series B (25)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (426)
Stomach cancer (2)
Substance use disorders (2)
Supply chain (14)
Vaccines (48)
Venture capital (7)
Weight loss (18)
Women's health (8)
Date
Today (9)
Last 7 days (56)
Last 30 days (239)
Last 365 days (2841)
2026 (2104)
2025 (2683)
2024 (3252)
2023 (3815)
2022 (7003)
2021 (6372)
2020 (5871)
2019 (3858)
2018 (3010)
2017 (3558)
2016 (3171)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (88)
Alabama (5)
Arizona (14)
Arkansas (1)
Asia (22380)
Australia (2499)
California (871)
Canada (499)
China (556)
Colorado (5)
Connecticut (29)
Delaware (9)
Europe (13565)
Florida (96)
Georgia (18)
Hawaii (1)
Illinois (46)
India (62)
Indiana (29)
Japan (371)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (137)
Massachusetts (693)
Michigan (9)
Minnesota (39)
Missouri (3)
Nebraska (3)
Nevada (13)
New Hampshire (1)
New Jersey (543)
New York (300)
North Carolina (132)
Northern California (375)
Ohio (7)
Oregon (1)
Pennsylvania (163)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (429)
Tennessee (6)
Texas (65)
United States (3346)
Utah (35)
Vermont (1)
Virginia (68)
Washington D.C. (3)
Washington State (64)
Wisconsin (8)
Wyoming (1)
73,854 Results for "polypid ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PolyPid Announces Participation in Upcoming Fall Investor Conferences
September 15, 2026
·
2 min read
Press Releases
PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 12, 2026
·
13 min read
Press Releases
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
July 29, 2026
·
6 min read
Press Releases
PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
July 30, 2026
·
1 min read
Press Releases
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
June 1, 2026
·
5 min read
Press Releases
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
May 20, 2026
·
1 min read
Press Releases
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
July 21, 2026
·
8 min read
Press Releases
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 13, 2026
·
11 min read
Press Releases
PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA
March 31, 2026
·
5 min read
Press Releases
PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026
May 6, 2026
·
1 min read
1 of 7,386
Next
